Factor VIII (Anti Haemophilic)

FACTOR VIII (ANTI HAEMOPHILIC) Test

The Factor VIII (Anti-Haemophilic Factor) test measures the activity of clotting factor VIII, an essential protein involved in the blood-clotting process. Adequate factor VIII activity helps the body form stable blood clots and control bleeding.

The test is primarily used to investigate hemophilia A, an inherited bleeding disorder caused by reduced or absent factor VIII activity. It can also help determine the severity of factor VIII deficiency and may be used to monitor patients receiving factor VIII replacement therapy.

Factor VIII activity may also be reduced in certain acquired conditions, including acquired hemophilia A. Results are generally interpreted along with aPTT, other coagulation factor tests, bleeding history, and clinical findings.

This Test is Recommended for Individuals:

• Individuals with suspected hemophilia A
• Patients with unexplained or recurrent bleeding
• People with a family history of inherited bleeding disorders
• Individuals with an unexplained prolonged aPTT
• Patients being evaluated for a suspected clotting factor deficiency
• Individuals with known hemophilia A requiring treatment monitoring
• Patients receiving factor VIII replacement therapy

FAQs

1. What does the Factor VIII test measure?
It measures the functional activity of clotting factor VIII, which is necessary for normal blood clot formation.

2. What does low Factor VIII activity indicate?
Low factor VIII activity may indicate hemophilia A or another factor VIII deficiency. The severity depends on the level of activity and the individual's bleeding history.

3. Is Factor VIII testing used to monitor hemophilia treatment?
Yes. Factor VIII activity testing can help healthcare providers monitor factor replacement therapy and assess whether treatment is achieving the desired factor VIII level.